Kimberly-Clark Co. (NYSE:KMB) Shares Bought by Fidelis Capital Partners LLC

Fidelis Capital Partners LLC lifted its stake in shares of Kimberly-Clark Co. (NYSE:KMB) by 44.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,455 shares of the company’s stock after acquiring an additional 448 shares during the period. Fidelis Capital Partners LLC’s holdings in Kimberly-Clark were worth $204,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Frank Rimerman Advisors LLC grew its holdings in shares of Kimberly-Clark by 12,203.4% during the second quarter. Frank Rimerman Advisors LLC now owns 3,568 shares of the company’s stock worth $493,000 after buying an additional 3,539 shares in the last quarter. Kowal Investment Group LLC lifted its stake in shares of Kimberly-Clark by 11.0% during the second quarter. Kowal Investment Group LLC now owns 4,077 shares of the company’s stock valued at $563,000 after buying an additional 404 shares during the period. Merriman Wealth Management LLC acquired a new stake in Kimberly-Clark during the second quarter worth approximately $212,000. Summit Trail Advisors LLC grew its stake in Kimberly-Clark by 12.8% in the 2nd quarter. Summit Trail Advisors LLC now owns 5,929 shares of the company’s stock worth $827,000 after acquiring an additional 673 shares during the period. Finally, Thrivent Financial for Lutherans raised its holdings in Kimberly-Clark by 4.1% in the 2nd quarter. Thrivent Financial for Lutherans now owns 29,018 shares of the company’s stock valued at $4,010,000 after acquiring an additional 1,155 shares during the last quarter. Hedge funds and other institutional investors own 76.29% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on KMB. BNP Paribas assumed coverage on Kimberly-Clark in a report on Monday, June 24th. They set a “neutral” rating and a $146.00 price objective on the stock. TD Cowen started coverage on Kimberly-Clark in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $161.00 price target on the stock. Argus raised shares of Kimberly-Clark to a “hold” rating in a research note on Friday, July 26th. JPMorgan Chase & Co. raised their target price on shares of Kimberly-Clark from $123.00 to $135.00 and gave the stock an “underweight” rating in a research report on Monday, July 22nd. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of Kimberly-Clark from $139.00 to $142.00 and gave the company a “hold” rating in a report on Wednesday, July 24th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, Kimberly-Clark has a consensus rating of “Hold” and a consensus price target of $145.67.

Insider Buying and Selling

In other Kimberly-Clark news, insider Gonzalo Uribe sold 1,780 shares of the stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $140.84, for a total value of $250,695.20. Following the completion of the sale, the insider now owns 7,377 shares of the company’s stock, valued at $1,038,976.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Kimberly-Clark news, insider Jeffrey P. Melucci sold 37,699 shares of the business’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $141.42, for a total value of $5,331,392.58. Following the transaction, the insider now owns 19,935 shares in the company, valued at approximately $2,819,207.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gonzalo Uribe sold 1,780 shares of the firm’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $140.84, for a total value of $250,695.20. Following the sale, the insider now owns 7,377 shares of the company’s stock, valued at $1,038,976.68. The disclosure for this sale can be found here. 0.62% of the stock is currently owned by corporate insiders.

Kimberly-Clark Price Performance

KMB opened at $141.21 on Tuesday. Kimberly-Clark Co. has a 52-week low of $116.32 and a 52-week high of $149.30. The company has a 50 day moving average of $142.30 and a two-hundred day moving average of $136.29. The company has a market cap of $47.55 billion, a P/E ratio of 25.96, a P/E/G ratio of 3.04 and a beta of 0.39. The company has a quick ratio of 0.58, a current ratio of 0.85 and a debt-to-equity ratio of 5.59.

Kimberly-Clark (NYSE:KMB) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $1.96 earnings per share for the quarter, topping analysts’ consensus estimates of $1.71 by $0.25. Kimberly-Clark had a net margin of 11.28% and a return on equity of 223.55%. The firm had revenue of $5.03 billion during the quarter, compared to analysts’ expectations of $5.10 billion. During the same period in the prior year, the company earned $1.65 EPS. The firm’s revenue was down 2.0% on a year-over-year basis. On average, analysts expect that Kimberly-Clark Co. will post 7.25 earnings per share for the current year.

Kimberly-Clark Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 2nd. Investors of record on Friday, September 6th will be issued a dividend of $1.22 per share. The ex-dividend date is Friday, September 6th. This represents a $4.88 annualized dividend and a dividend yield of 3.46%. Kimberly-Clark’s payout ratio is currently 89.71%.

Kimberly-Clark Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.